Feature | August 26, 2010

Polymer Bottle Packaging Receives GE's Ecomaginationsm Approval


August 25, 2010 - GE Healthcare announced that polymer bottle packaging is now included in the company’s ecomagination campaign. +PLUSPAK, a packaging container for contrast media, offers advantages over traditional glass packaging that includes reduced storage, improved workplace safety for healthcare workers who administer contrast media to patients, and decreased cost of waste disposal.

Radiology departments using the innovative GE Healthcare +PLUSPAK packaging can reduce contrast media red bag waste weight by more than 75 percent. +PLUSPAK is made of unbreakable polypropylene and features a metal-free, twist-off cap that is easy to open and avoids cuts from metal crimps.

A survey conducted by the College of Radiographers showed that by replacing traditional contrast media glass packaging with GE Healthcare’s +PLUSPAK, a department of 24 radiographers could eliminate sharps wounds associated with glass packaging.

The same survey showed that the department could improve productivity by saving approximately 3.5 hours a month typically spent treating sharps injuries while also reducing the associated risk of bloodborne pathogen transmission.

+PLUSPAK packaging dovetails with the GE’s ecomagination criteria for improving workplace safety and convenience. +PLUSPAK packaging offers significant timesaving, cost-saving and environmental advantages over the glass packaging traditionally used to package contrast media.

For more information: www.pluspak.com.au


Related Content

News | Contrast Media

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

Home August 17, 2023
Home
News | Contrast Media

July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home July 03, 2023
Home
News | Contrast Media

May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

Home May 11, 2021
Home
Technology | Contrast Media

July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic ...

Home July 15, 2019
Home
Videos | Contrast Media

Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax ...

Home June 28, 2019
Home
Feature | Contrast Media | Dave Fornell, Editor

Iodine-based contrast agents used in computed tomography (CT) and catheter-based angiography have been implicated as a ...

Home May 31, 2019
Home
News | Contrast Media

May 9, 2019 — Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing safety ...

Home May 09, 2019
Home
News | Contrast Media

November 30, 2018 — VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that ...

Home November 30, 2018
Home
News | Contrast Media

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore ...

Home September 12, 2018
Home
News | Contrast Media

January 19, 2018 — Ligand Pharmaceuticals Inc. announced initiation of a program to develop contrast agents with reduced ...

Home January 19, 2018
Home
Subscribe Now